The DSCSA mandates that by November 2023, prescription drug products must be electronically tracked through the supply chain to combat counterfeiting. Healthcare distributors are making significant progress in setting up electronic connections to meet the goal of interoperability by 2023.

Today, it’s not enough to just react to regulatory requirements. You also need to be able to analyze, understand and make real-time business decisions based on data generated by tracking and tracing.